Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X), 1 mL
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471378
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $286.65
About this award
The University of Virginia awarded contract A207_PO-0471378 to Life Technologies Corporation on August 20, 2026, for the procurement of laboratory reagents. The contract encompasses the delivery of Halt Protease and Phosphatase Inhibitor Cocktail, Ethylenediaminetetraacetic acid (EDTA)-free formulation, concentrated at 100 times strength (100X), in a 1 milliliter unit. The total contract value is $286.65, with a unit price of $286.65 per item ordered in a single quantity of one unit.
The deliverable is to be received by Marcus Jerryd Meade at the University of Virginia in Virginia. No specific period of performance beyond the award date of August 20, 2026, is documented in the contract information provided. Life Technologies Corporation serves as the prime contractor responsible for fulfilling this purchase order, which represents a routine procurement of specialized laboratory biochemical products for research or diagnostic applications.
Line items
| Item | Total |
|---|---|
| Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X), 1 mL | $286.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471378?
Contract A207_PO-0471378 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 20, 2026.
How much is contract A207_PO-0471378 worth?
Its cumulative value is $286.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award